Fig. 7
Proptosis response with teprotumumab stratified by race, gender and smoking status. Note: 1 patient did not receive the full course of treatment but had measurements at week 24
Fig. 7 | Eye
Proptosis response with teprotumumab stratified by race, gender and smoking status. Note: 1 patient did not receive the full course of treatment but had measurements at week 24
